Imunon, Inc. reported on June 9, 2025, that it has regained compliance with Nasdaq's minimum bid price requirement after its stock traded above $1.00 for 10 consecutive days, following a delisting determination letter received on May 28, 2025. Additionally, recent warrant exercises provided the company with $2 million in proceeds, increasing stockholders' equity to $3 million as of May 31, 2025.